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Bacterial pathogenesis: A variation on variation in Lyme disease
Michael Koomey
The discovery of antigenic variation in Borrelia
burgdorferi, the bacterium that causes Lyme disease,
provides a potential explanation for the chronic nature
of infection as well as new insights into the genetic
structure of highly recombinogenic loci responsible for
combinatorial genetic diversification.
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Microbial pathogens evolve many strategies aimed at
evading the immunoprotective surveillance systems that
operate in mammals. Perhaps the most direct counter-
measure to the humoral wing of the immune system —
the part involving recognition by specific antibodies — is
antigenic variation, the process in which the primary struc-
ture and antigenicity of key surface proteins are altered
without perturbing their function(s). These changes are
achieved almost without exception by the reassortment
and recombination of repeated genes or gene segments
[1]. Such combinatorial mechanisms of genetic diversifica-
tion have been found to underlie high frequency changes
in the surface components of a wide variety of pathogens
— trypanosomes [2], malaria parasites [3], relapsing-fever-
causing Borrelia species [4] and the gonorrheal agent
Neisseria gonorrhoeae [5]. And now the Lyme disease
pathogen, Borrelia burgdorferi can be added to this list; the
recent discovery of antigenic variation in this species may
explain the chronic nature of Lyme disease.
In each of the pathogens that have been found to exhibit
antigenic variation, the phenomenon has been discovered
and characterized by a sequence of observations starting
with biochemical and immunochemical documentation of
inter-strain, and subsequently intra-strain, variation of a
predominant surface component. This initial observation
was followed by cloning of the structural gene encoding
the variable surface component, and the identification of
multiple copies of related but divergent gene copies or
elements. It then became a relatively straightforward
matter (in retrospect) to document the DNA rearrange-
ments and recombination of related genes that are respon-
sible for the antigenic variation. 
Relapsing fever, caused by Borreliae hermsii and related
species, is arguably the best understood disease involving
antigenic variation. The initial infection occurs during the
bite from an infected tick, or a louse during epidemics,
and following this the infected animal undergoes waves of
spirochetemia and accompanying fever. The relapses are
associated with the clonal emergence in the bloodstream
of a variant expressing a novel variable major protein [6].
After up to ten such waves of parasitemia, occurring every
four to seven days, the individual or animal can succumb
or recover completely. 
Lyme disease is a tick-borne infection caused by the
spirochete B. burgdorferi, which is related to the relapsing
fever borreliae [7]. In stark contrast to relapsing fever,
which has been relatively quiescent for almost 50 years,
Lyme disease is currently the most common arthropod-
borne disease in both North America and Europe.
Although rarely fatal, the manifestations of Lyme disease
can be physically and emotionally debilitating [7]. Early
human infection is usually characterized by a spreading
skin rash (erythema migrans) and flu-like illness, which is
self-limiting. In the following weeks to months, most
untreated infected individuals proceed into a chronic late
disease characterized by systemic involvement of the
joints, brain, nerves, eyes and heart [8]. 
From these presentations alone, it seemed likely that
antigenic variation would play a role in the immune eva-
siveness displayed by B. burgdorferi. Subtle differences in
highly expressed surface lipoproteins were found between
B. burgdorferi strains, but no compelling evidence for
major antigenic changes [9] or gross genetic rearrange-
ments [10] was initially forthcoming, despite indirect evi-
dence suggesting that antigenic shifts can occur during
mouse infection [11,12]. One major problem has been that
there are as yet no experimental animal models that mimic
the course of Lyme disease and in which spirochetemias
can be detected. To complicate matters further, basic
methodologies for gene transfer and mutant isolation in
borrelia spirochetes have been slow in developing.
In the absence of many of the reagents that play such an
important part in current studies of bacterial infectious
disease, it is not surprising that the identification of anti-
genic variation in Lyme disease borreliae came about
through a rather circuitous series of findings and experi-
ments. This story begins in much the same way as many
of the early studies of microbial pathogenesis, with the
observation that passage of the organism in the laboratory
leads to the recovery of variants or mutants of reduced vir-
ulence. In the case of Lyme disease borreliae, it was well
documented that they lose their ability to infect laboratory
animals following ten or more blind in vitro passages
[13,14]. Attempts to define the genetic basis for this atten-
uation phenomenon were complicated by the weaknesses
of the system noted above. Moreover, B. burgdorferi con-
tains a linear chromosome and a complex set of multiple
circular and linear plasmid DNA species. The extrachro-
mosomal plasmid profiles exhibit instability during labora-
tory cultivation, but it was difficult to correlate the
presence of particular plasmids or known surface compo-
nents with infectivity [15].
As the low-infectivity B. burgdorferi strains failed to give
rise to virulent revertants in animals, Zhang et al. [16]
surmised that the loss of one or more of the extrachromo-
somal elements might account for the irreversible
genetic alteration. By using subtractive hybridization,
they went on to identify sequences that are present only
in high-infectivity strains. Characterization of one of the
resulting clones revealed the presence of a single open
reading frame, encoding a putative protein with greater
than 25% amino acid sequence identity to a variable
membrane lipoprotein (Vmp) of B. hermsii, the relapsing
fever agent. 
Using this clone as a DNA probe, Zhang et al. [16] were
able to establish that the Vmp-like sequence (vls) resides
on a 28 kilobase (kb) linear plasmid that was absent from
the vast majority of low-infectivity strains enriched during
in vitro passage. Further sequence characterization of the
linear plasmid revealed the presence of an extensive vls
locus consisting of a single telomeric gene expression site,
vlsE, and 15 tandemly arrayed, non-expressed vls cassettes
whose derived peptide sequences correspond to the
central 200 residues of the predicted vlsE product. In light
of the finding that the central segments encoded by the
vls cassettes were closely related but not identical to one
another, the genetic foundation for VlsE antigenic vari-
ability was established.
From findings in other systems that exhibit antigenic
variation, it was expected that genetic recombination
between the variant-encoding vls cassettes and the
expressed locus would turn out to be the mechanism that
generates VlsE antigenic variability. To examine this pos-
sibility, Zhang et al. [16] compared the vlsE DNA
sequences from clones recovered from mice following four
weeks of infection. By comparison with the vlsE of the
inoculum clone, numerous nucleotide substitutions, inser-
tions and deletions were found in the gene from each
reisolate, which could only be accounted for by repeated
rounds of templated recombination with individual vls
cassettes. As a climax to the work, they demonstrated that
the products of these vlsE alleles display altered levels of
immunoreactivity with sera raised against the parental
VlsE, sera from a white-footed mouse (the natural host for
B. burgdorferi) infected by a tick bite, and sera from a
human Lyme disease patient.
Given the similarity in sequence of the B. burgdorferi Vls
and B. hermsii Vmp proteins, it is surprising that their
mechanisms of antigen variation are so different. In relaps-
ing fever, non-expressed B. hermsii vmp genes — of which
there are more than 25 per strain — are carried in linear,
storage plasmids whereas the single active gene — the
expression locus — is telomerically located on a distinct
linear plasmid [17]. Antigenic variation in B. hermsii occurs
by partial or complete replacement of the vmp gene at the
expression locus by any one of the silent vmp gene copies.
[4,18,19]. Many facets of this process are similar to the
mechanism of antigenic variation of surface glycoproteins
in African trypanosomes [2]. 
Antigenic variation of the Lyme disease agent B. burgdor-
feri, in contrast, involves the use of partial gene segments
that are tightly clustered immediately upstream of the vls
expression locus, an arrangement that is more similar in its
overall design to what is seen in the avian immunoglobu-
lin [20] and N. gonorrhoeae pilin [21] combinatorial diversi-
fication systems. In each of these three systems, despite
the fact that a relatively small number of non-expressed
alleles or pseudogenes are used as templates, an extremely
high level of diversity is achieved by multiple rounds of
recombination with different donor alleles or different
length tracts of a single allele. 
The key to each of these systems appears to be the ability
to undergo efficient intragenic recombination within short
homologous segments of nucleotides, which encode con-
served domains within the proteins. A second common
feature of these systems is the extremely high frequency
with which variants arise in vivo compared with that occur-
ring in vitro. For example, in the chicken, the complete
pre-immune repertoire of immunoglobulin light chain
genes is generated within the bursa of Fabricius in a
matter of days by multiple segmental recombination
events between a single rearranged variable (V) gene and
25 V pseudogenes [20]. Pilus expression by N. gonorrhoeae
is quite stable in the laboratory, whereas an extensive
mixture of antigenic variants are found at the earliest time
points following infection [5,22]. For B. burgdorferi, Zhang
et al. [16] have coined the term ‘promiscuous’ recombina-
tion to describe the extensive vls rearrangements that they
suggest are induced when in the mammalian host. It will
be very exciting to see what role the conserved gene orga-
nization of these systems plays in high frequency gene-
conversion-like events, and what signals are responsible
for the enhanced recombination rates seen in vivo.
The potential impact of the discovery of Vls antigenic
variation on the study of Lyme disease pathogenesis is
enormous. As is so often the case with scientific break-
throughs, many important and readily obvious questions
can now be addressed. Does Vls antigenic variation occur
in infected humans? What is the function of the Vls
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protein? Is the loss of infectivity of in vitro passaged clones
accounted for by their lack of vls expression, or is it associ-
ated with another plasmid-encoded product? 
With regard to immunization against Lyme disease, it will
be of interest to determine if antibodies directed at con-
served Vls domains are protective or modify the course of
Vls variation. By chance, the new findings have come at a
time when favorable results of phase III human vaccine
trials with antigenically stable borrelia antigens are being
reported. But as we have learned from other vaccines as
well as from antibiotics and the development of resistance,
current formulations can almost always be improved and
the discovery of Vls may have important implications for a
second generation of Lyme disease vaccines. The new
findings also coincide with the impending completion of
the B. burgdorferi genome sequence and the first report of
gene transfer in borrelia [23], so it seems assured that
research into this important pathogen will proceed at an
accelerated pace.
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